Article Information
History
- November 27, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alex Tokolyi1,21,
- Elodie Persyn2,3,4,21,
- Artika P. Nath4,5,
- Katie L. Burnham1,
- Jonathan Marten2,
- Thomas Vanderstichele1,
- Manuel Tardaguila1,6,
- David Stacey2,7,8,
- Ben Farr1,
- Vivek Iyer1,
- Xilin Jiang2,3,9,
- Samuel A. Lambert2,3,4,10,
- Guillaume Noell1,
- Michael A. Quail1,
- Diana Rajan1,
- Scott C. Ritchie2,3,4,5,10,11,
- Benjamin B. Sun12,
- Scott A.J. Thurston1,
- Yu Xu2,3,4,
- Christopher D. Whelan13,
- Heiko Runz12,
- Slavé Petrovski14,15,
- Daniel J. Gaffney1,16,
- David J. Roberts17,18,
- Emanuele Di Angelantonio2,3,6,10,11,19,
- James E. Peters20,
- Nicole Soranzo1,6,
- John Danesh1,2,3,10,11,19,
- Adam S. Butterworth2,3,10,11,19,
- Michael Inouye2,3,4,5,10,11,21,
- Emma E. Davenport1,21 and
- Dirk S. Paul2,3,14,21,*
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
- 2British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 3Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
- 4Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
- 6Human Technopole, Fondazione Human Technopole, Milan, Italy
- 7Australian Centre for Precision Health, University of South Australia, Adelaide, SA, Australia
- 8South Australian Health and Medical Research Institute, Adelaide, SA, Australia
- 9Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 10Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
- 11British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
- 12Translational Sciences, Research & Development, Biogen, Cambridge, MA, USA
- 13Neuroscience Data Science, Janssen Research & Development, Cambridge, MA, USA
- 14Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 15Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia
- 16Genomics, BioMarin Pharmaceutical Inc., Novato, CA, USA
- 17Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, UK
- 18Clinical Services, NHS Blood and Transplant, Oxford Centre, John Radcliffe Hospital, Oxford, UK
- 19NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK
- 20Department of Immunology and Inflammation, Imperial College London, London, UK
- ↵*Correspondence: Dirk Paul, dirk.paul{at}astrazeneca.com
↵21 These authors contributed equally
Posted November 27, 2023.
Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes
